Does the media refer more to SHC or ARDT?

In the previous week, Ardent Health had 2 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Ardent Health and 1 mentions for Sotera Health. Ardent Health's average media sentiment score of 0.32 beat Sotera Health's score of 0.00 indicating that Ardent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ardent Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAI or ARDT?

In the previous week, Caris Life Sciences and Caris Life Sciences both had 3 articles in the media. Ardent Health's average media sentiment score of 0.32 beat Caris Life Sciences' score of -0.24 indicating that Ardent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Ardent Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, RDNT or ARDT?

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.09 -$18.65M -$0.18 N/A Ardent Health $6.32B 0.20 $135.81M $0.95 9.19

Is RDNT or ARDT more profitable?

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Ardent Health 2.09% 13.85% 4.48%

Does the media refer more to RDNT or ARDT?

In the previous week, RadNet had 3 more articles in the media than Ardent Health. MarketBeat recorded 6 mentions for RadNet and 3 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.32 beat RadNet's score of 0.00 indicating that Ardent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ardent Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, BLLN or ARDT?

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 14.65 $7.45M $0.55 176.71 Ardent Health $6.32B 0.20 $135.81M $0.95 9.19

Does the media favor BLLN or ARDT?

In the previous week, Ardent Health had 1 more articles in the media than Billiontoone. MarketBeat recorded 3 mentions for Ardent Health and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.22 beat Ardent Health's score of 0.32 indicating that Billiontoone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, VCYT or ARDT?

Ardent Health has higher revenue and earnings than Veracyte. Ardent Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $517.15M 7.52 $66.35M $1.09 44.71 Ardent Health $6.32B 0.20 $135.81M $0.95 9.19

Does the media refer more to VCYT or ARDT?

In the previous week, Veracyte had 19 more articles in the media than Ardent Health. MarketBeat recorded 22 mentions for Veracyte and 3 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.32 beat Veracyte's score of 0.26 indicating that Ardent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Ardent Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Ardent Health (ARDT) Competitors

$8.73 +0.13 (+1.55%)

Closing price 03:59 PM Eastern

Extended Trading

$8.50 -0.23 (-2.68%)

As of 06:32 PM Eastern

Compare

ARDT vs. SHC, CAI, RDNT, BLLN, and VCYT

Should you buy Ardent Health stock or one of its competitors? MarketBeat compares Ardent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ardent Health include Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), Billiontoone (BLLN), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Ardent Health compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.83	$77.94M	$0.41	38.10
Ardent Health	$6.32B	0.20	$135.81M	$0.95	9.19

Sotera Health has a net margin of 9.91% compared to Ardent Health's net margin of 2.09%. Sotera Health's return on equity of 39.73% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Ardent Health	2.09%	13.85%	4.48%

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 1.9% of Ardent Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Ardent Health had 2 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Ardent Health and 1 mentions for Sotera Health. Ardent Health's average media sentiment score of 0.32 beat Sotera Health's score of 0.00 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sotera Health has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market.

Sotera Health presently has a consensus price target of $20.29, suggesting a potential upside of 29.87%. Ardent Health has a consensus price target of $14.21, suggesting a potential upside of 62.70%. Given Ardent Health's higher possible upside, analysts plainly believe Ardent Health is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Sotera Health beats Ardent Health on 10 of the 16 factors compared between the two stocks.

How does Ardent Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

In the previous week, Caris Life Sciences and Caris Life Sciences both had 3 articles in the media. Ardent Health's average media sentiment score of 0.32 beat Caris Life Sciences' score of -0.24 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Caris Life Sciences presently has a consensus target price of $27.56, suggesting a potential upside of 67.10%. Ardent Health has a consensus target price of $14.21, suggesting a potential upside of 62.70%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Caris Life Sciences is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Ardent Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.74	-$68.09M	-$7.61	N/A
Ardent Health	$6.32B	0.20	$135.81M	$0.95	9.19

Caris Life Sciences has a net margin of 3.75% compared to Ardent Health's net margin of 2.09%. Caris Life Sciences' return on equity of 98.28% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Ardent Health	2.09%	13.85%	4.48%

Summary

Caris Life Sciences and Ardent Health tied by winning 6 of the 12 factors compared between the two stocks.

How does Ardent Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

In the previous week, RadNet had 3 more articles in the media than Ardent Health. MarketBeat recorded 6 mentions for RadNet and 3 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.32 beat RadNet's score of 0.00 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

RadNet presently has a consensus target price of $87.43, suggesting a potential upside of 60.89%. Ardent Health has a consensus target price of $14.21, suggesting a potential upside of 62.70%. Given Ardent Health's higher possible upside, analysts clearly believe Ardent Health is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Ardent Health	2.09%	13.85%	4.48%

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 1.9% of Ardent Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.09	-$18.65M	-$0.18	N/A
Ardent Health	$6.32B	0.20	$135.81M	$0.95	9.19

Summary

Ardent Health beats RadNet on 10 of the 17 factors compared between the two stocks.

How does Ardent Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Ardent Health has a net margin of 2.09% compared to Billiontoone's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Ardent Health	2.09%	13.85%	4.48%

In the previous week, Ardent Health had 1 more articles in the media than Billiontoone. MarketBeat recorded 3 mentions for Ardent Health and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.22 beat Ardent Health's score of 0.32 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ardent Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone presently has a consensus target price of $125.29, indicating a potential upside of 28.91%. Ardent Health has a consensus target price of $14.21, indicating a potential upside of 62.70%. Given Ardent Health's higher possible upside, analysts clearly believe Ardent Health is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.65	$7.45M	$0.55	176.71
Ardent Health	$6.32B	0.20	$135.81M	$0.95	9.19

Summary

Ardent Health beats Billiontoone on 9 of the 13 factors compared between the two stocks.

How does Ardent Health compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Veracyte has a net margin of 16.25% compared to Ardent Health's net margin of 2.09%. Ardent Health's return on equity of 13.85% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Ardent Health	2.09%	13.85%	4.48%

Ardent Health has higher revenue and earnings than Veracyte. Ardent Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	7.52	$66.35M	$1.09	44.71
Ardent Health	$6.32B	0.20	$135.81M	$0.95	9.19

In the previous week, Veracyte had 19 more articles in the media than Ardent Health. MarketBeat recorded 22 mentions for Veracyte and 3 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.32 beat Veracyte's score of 0.26 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Ardent Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Veracyte has a beta of 1.98, indicating that its share price is 98% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Veracyte presently has a consensus target price of $47.57, suggesting a potential downside of 2.38%. Ardent Health has a consensus target price of $14.21, suggesting a potential upside of 62.70%. Given Ardent Health's higher possible upside, analysts plainly believe Ardent Health is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Veracyte beats Ardent Health on 9 of the 15 factors compared between the two stocks.

Get Ardent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ARDT vs. The Competition

Export

Metric	Ardent Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.23B	$8.83B	$6.48B	$23.37B
Dividend Yield	N/A	1.77%	2.67%	4.07%
P/E Ratio	9.19	22.29	23.93	30.27
Price / Sales	0.20	20.38	517.31	22.09
Price / Cash	3.13	91.45	42.35	24.41
Price / Book	0.74	5.20	9.73	4.63
Net Income	$135.81M	$175.77M	$3.56B	$1.07B
7 Day Performance	-5.17%	-2.19%	-3.19%	-1.64%
1 Month Performance	-13.77%	7.78%	-0.11%	-0.77%
1 Year Performance	-40.63%	5.10%	25.29%	22.61%

Ardent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ARDT Ardent Health	4.1534 of 5 stars	$8.73 +1.5%	$14.21 +62.7%	-41.1%	$1.23B	$6.32B	9.19	25,200
SHC Sotera Health	3.285 of 5 stars	$15.97 +2.0%	$20.33 +27.3%	+26.0%	$4.55B	$1.16B	38.95	3,000	Positive News Analyst Forecast
CAI Caris Life Sciences	4.7428 of 5 stars	$15.81 +1.7%	$27.56 +74.3%	N/A	$4.47B	$812.03M	N/A	1,846	Gap Down
RDNT RadNet	3.2717 of 5 stars	$54.58 +0.3%	$87.43 +60.2%	-7.0%	$4.29B	$2.04B	N/A	11,264	News Coverage
BLLN Billiontoone	4.6853 of 5 stars	$85.23 -0.8%	$125.29 +47.0%	N/A	$3.92B	$305.11M	154.96	620	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ARDT) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardent Health (ARDT) Competitors

ARDT vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Ardent Health compare to Sotera Health?

Summary

How does Ardent Health compare to Caris Life Sciences?

Summary

How does Ardent Health compare to RadNet?

Summary

How does Ardent Health compare to Billiontoone?

Summary

How does Ardent Health compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ardent Health (ARDT) Competitors

ARDT vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Ardent Health compare to Sotera Health?

Which has higher valuation and earnings, SHC or ARDT?

Is SHC or ARDT more profitable?

Do insiders and institutionals hold more shares of SHC or ARDT?

Does the media refer more to SHC or ARDT?

Which has more volatility & risk, SHC or ARDT?

Do analysts prefer SHC or ARDT?

Summary

How does Ardent Health compare to Caris Life Sciences?

Does the media refer more to CAI or ARDT?

Do analysts rate CAI or ARDT?

Which has higher earnings and valuation, CAI or ARDT?

Is CAI or ARDT more profitable?

Summary

How does Ardent Health compare to RadNet?

Does the media refer more to RDNT or ARDT?

Which has more risk and volatility, RDNT or ARDT?

Do analysts rate RDNT or ARDT?

Is RDNT or ARDT more profitable?

Do institutionals and insiders have more ownership in RDNT or ARDT?

Which has better valuation and earnings, RDNT or ARDT?

Summary

How does Ardent Health compare to Billiontoone?

Is BLLN or ARDT more profitable?

Does the media favor BLLN or ARDT?

Do analysts prefer BLLN or ARDT?

Which has higher earnings & valuation, BLLN or ARDT?

Summary

How does Ardent Health compare to Veracyte?

Is VCYT or ARDT more profitable?

Which has stronger valuation and earnings, VCYT or ARDT?

Does the media refer more to VCYT or ARDT?

Which has more risk & volatility, VCYT or ARDT?

Do analysts prefer VCYT or ARDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools